Free To Total Psa Ratio - Cancer Science

Relevant Publications

Associations of systemic immune-inflammation index with high risk for prostate cancer in middle-aged and older US males: A population-based study.

Issue Release: 2024

RECIP 1.0 Predicts Progression-Free Survival After [Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Issue Release: 2024

Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study.

Issue Release: 2024

The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort.

Issue Release: 2024

Is the Free-to-Total PSA Ratio Less Important Than PSA Density and PSA Velocity in Patients With Negative MRI Examinations?

Issue Release: 2024

Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trial.

Issue Release: 2024

Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mL.

Issue Release: 2024

Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?

Issue Release: 2024

Serological proteomic profiling uncovered CDK5RAP2 as a novel marker in benign prostatic hyperplasia.

Issue Release: 2024

SERS-Temperature Dual-Mode T-type Lateral Flow Strip for Accurate Detection of Free and Total Prostate-Specific Antigens in Blood.

Issue Release: 2024

Nomograms for predicting clinically significant prostate cancer in men with PI-RADS-3 biparametric magnetic resonance imaging.

Issue Release: 2024

Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA.

Issue Release: 2024

Real‑world retrospective study of early‑stage prostate cancer at a Portuguese Comprehensive Cancer Centre: The PEarlC study.

Issue Release: 2024

Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound.

Issue Release: 2024

Cost-Effectiveness of Adjuvant Abemaciclib and Ribociclib in High-Risk Hormone Receptor-Positive Early Breast Cancer: An Indian Perspective.

Issue Release: 2024

[Clinical significance of prostatic exosomal protein and PSA in detecting prostate cancer with the PSA gray zone and PI-RADS-3 lesions].

Issue Release: 2024

Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL.

Issue Release: 2024

Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia.

Issue Release: 2024

Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort.

Issue Release: 2024

Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.

Issue Release: 2024

What is Photodegradation?

What is the Role of NHS in Cancer Care?

What is the Link Between HTLV-1 and Cancer?

What Should You Look for During a Skin Check?

What Are Anxiolytic Medications?

How Do Lipase Inhibitors Work in Cancer?

How Can Cancer Patients Find a Reputable Medical Billing Advocate?

What are Routes of Administration?

Are There Alternatives to Traditional Screening Tests?

What is Obesity?

Free To Total Psa Ratio - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics